000			04267nam a22004335i 4500
710	2		_aSpringerLink (Online service) _9106996
999			_c117125 _d117125 _x1
001			117125
003			ES-MaUEC
005			20230102113810.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			190611s2019 si | s |||| 0|eng d
020			_a9789811374586
024	7		_a10.1007/978-981-13-7458-6 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC257 .R3 _b2019 EB
245	0	0	_aNuclear Medicine in Oncology _bMolecular Imaging and Target Therapy _cedited by Gang Huang.
250			_a1st ed. 2019.
264		1	_aSingapore _bSpringer Singapore : _bImprint: Springer _c2019.
300			_a1 recurso en línea (XI, 346 páginas) _b247 ilustraciones, 157 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_a1. Glucose Metabolism Imaging -- 2. Clinical Utility of 18F-FDG PET/CT in Breast Cancer Management and Targeted Therapy -- 3. The application of 18F-FDG PET/CT in diagnose and therapy of non-small cell lung cancer -- 4. Clinical application of 18F-FDG PET/CT in lymphoma -- 5. Clinical utility of 18F-FDG PET/CT scanning in urological cancers management -- 6. Gynecologic tumor PET / CT imaging -- 7. Molecular imaging and targeted therapy of gastrointestinal cancer -- 8. Head and Neck Cancer -- 9. Molecular imaging and targeted therapy of malignant melanoma -- 10. Role of 18F-FDG PET/CT in Pediatric Oncology -- 11. Molecular imaging -- 12. Receptor targeted radionuclide imaging (RTRI) and peptide receptor radionuclide therapy (PRRT) -- 13. Radioimmunoimaging and targeted therapy -- 14. Apoptosis imaging -- 15. Radionuclide gene and reporter gene imaging -- 16. Na+/I− symporter target for thyroid disease imaging and treatment -- 17. Molecular Imaging and Targeted Therapy In Neurology -- 18. Nuclear cardiolgy -- 19. Equipment for imaging and mechanism, radiation protection -- 20. Molecular imaging probe.
520			_aThis book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively. This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.
988			_aSpringer_Medicine_2019
650		7	_2embne _aOncología _9139207
650		7	_2embne _9139209 _aTumores
700	1		_aHuang, Gang _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9789811374579
776	0	8	_iPrinted edition: _z9789811374593
776	0	8	_iPrinted edition: _z9789811374609
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-7458-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _cm _dz _feng _ggw _h0 _b01/2020 _eIG _zSI